Imugene Ltd News

Imugene Ltd: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings

Dec 20 10:20

Imugene Ltd: Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund

Dec 19 05:54

Imugene Ltd: onCARlytics Trial Doses First Patient in IT Combination Arm

Nov 11 06:03

Imugene Ltd: Imugene Opens First Australian Site for azer-cel Trial

Nov 8 07:08

Imugene Ltd: Complete Response in MAST Study Maintained Over Two Years

Nov 5 06:04

Imugene Ltd: Imugene Receives Orphan Drug Designation for VAXINIA

Sep 18 11:06

Imugene Ltd: Imugene Webinar - Azer-cel Trial Update

Sep 3 06:26

Imugene Ltd: Three Complete Responses in Azer-Cel Phase 1b Trial

Sep 2 06:44

Imugene Ltd: Imugene ESG Report 2024

Aug 30 16:44

Imugene Ltd: Corporate Governance Statement 2024 and Appendix 4G

Aug 30 16:43

Imugene Ltd: Release of Shares from Voluntary Escrow

Aug 2 15:59

Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 31 07:16

Imugene Ltd: First patient dosed in Phase 1 bile tract cancer trial

Jul 10 07:20

Imugene Ltd: Change of Director's Interest Notice x6

Jul 8 14:50

Imugene Ltd: Imugene onCARlytics Doses First Patient in IV Combination

Jun 24 06:24

Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 06:48

Imugene Ltd: Change of Director's Interest Notice - PH

Apr 23 14:50

Imugene Ltd: Imugene & Kincell Bio Strategic Partnership Investor Webinar

Apr 17 08:31

Imugene Ltd: Imugene and Kincell Bio Announce Strategic Partnership

Apr 16 06:34

Imugene Ltd: Bile Tract Cancer Study Opens after MAST High Dose Clearance

Apr 15 06:36